Skip to main content
Valbiotis logo

Valbiotis — Investor Relations & Filings

Ticker · ALVAL ISIN · FR0013254851 LEI · 969500VP4JBJCF0MOP60 PA Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country FR France
Listing PA ALVAL

About Valbiotis

https://www.valbiotis.com/en/

Valbiotis is a research and development company that develops and commercializes plant-based dietary supplements for the prevention and management of metabolic diseases. The company's portfolio is centered on its patented "TOTUM" line of active substances, which undergo rigorous clinical trials to validate their efficacy. Key products include TOTUM•63 for reducing blood glucose in prediabetic individuals, TOTUM•448 for cardio-liver health, and TOTUM•854 for managing blood pressure. Valbiotis provides scientifically proven, natural, non-drug solutions and is transitioning from a research-focused model to a commercial-stage enterprise.

Recent filings

Filing Released Lang Actions
VALBIOTIS SA: Valbiotis expands its e-commerce to Belgium and Luxembourg
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the expansion of Valbiotis’ e-commerce delivery to Belgium and Luxembourg. It does not contain financial results, regulatory filings, board changes, dividends, or other report types. It is a general announcement that does not fit any specific category, so it defaults to a Regulatory Filings (RNS) fallback.
2026-04-23 English
VALBIOTIS SA: Valbiotis ouvre son e-commerce à la Belgique et au Luxembourg
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing operational expansion (e-commerce delivery opening to Belgium and Luxembourg). It contains no financial results, no share capital changes, no board changes, no dividends, no regulatory report notices. This is a general business announcement falling into the fallback “Regulatory Filings” category (RNS).
2026-04-23 French
VALBIOTIS SA: Valbiotis expands its e-commerce to Belgium and Luxembourg
Regulatory Filings Classification · 1% confidence The document is a French Regulatory News Service press release announcing Valbiotis’ business update (e-commerce expansion) with no mention of financial results, governance changes, dividends, share issues, or other specific regulated actions. It does not fit any specific category (e.g., 10-K, IR, ER, DIV, SHA) and serves as a general corporate announcement under the regulatory news service. Therefore, it best fits the fallback category “Regulatory Filings” (RNS).
2026-04-23 English
VALBIOTIS SA: General Meeting of April 17, 2026: All Resolutions Approved
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release describing the outcome of the Combined General Meeting held on April 17, 2026, stating that “All Resolutions Approved” and detailing the renewal and appointment of Supervisory Board members. It reports official shareholder vote results (resolutions approved) rather than providing the AGM materials or full annual/interim financial statements. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements (DVA).”
2026-04-17 English
VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 17 avril 2026 : toutes les résolutions ont été adoptées
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release summarizing the outcomes of the mixed Annual General Meeting held on April 17, 2026, stating that all resolutions were adopted and detailing the renewal and appointment of Supervisory Board members. It reports the official vote results from an AGM, fitting the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-04-17 French
VALBIOTIS SA: General Meeting of April 17, 2026: All Resolutions Approved
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a regulatory press release announcing the outcome of a Combined General Meeting held April 17, 2026, explicitly stating that all resolutions were approved and detailing the vote results and board appointments. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.